Association between plasma immunoproteasome and 90-day prognosis after first-ever ischemic stroke

Association between plasma immunoproteasome and 90-day prognosis after first-ever ischemic stroke

Many blood biomarkers are reportedly helpful for predicting post-stroke cognitive impairment (PSCI), but no biomarkers are widely used in clinical practice. The purpose of this study was to investigate the association between the plasma immunoproteasome and patients’ 90-day prognosis after first-eve...

Full description

Bibliographic Details
Main Authors: Xing-Yong Chen, Ming Fu, Shao-Fen Wan, Xu Zhang, Yin-Zhou Wang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
behavior; biomarker; brain; clinical trial; cognitive impairment; immune function; neurological function; protein; stroke
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=4;spage=790;epage=795;aulast=Chen

Similar Items

Similar Items